SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 33.28 |
| Enterprise Value ($M) | -8.28 |
| Book Value ($M) | 20.44 |
| Book Value / Share | 8.40 |
| Price / Book | 1.63 |
| NCAV ($M) | 20.18 |
| NCAV / Share | 8.29 |
| Price / NCAV | 1.65 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.98 |
| Return on Assets (ROA) | -1.35 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.61 |
| Current Ratio | 6.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 46.20 |
| Assets | 46.46 |
| Liabilities | 26.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | MacAndrews & Forbes Inc. | 50.30 | -97.50 | |
| 13D | Baker Bros. Advisors Lp | 4.99 | ||
| 13D | Samsara BioCapital, L.P. | 10.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 3,126 | 10,711 | 29.18 | |
| 299 | 2,895 | 10.33 | |
| 141 | 3,422 | 4.12 | |
| 9 | 4,479 | 0.20 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VRPX – Virpax Pharmaceuticals, Inc. | VSTM – Verastem, Inc. |
| VTGN – Vistagen Therapeutics, Inc. | VXRT – Vaxart, Inc. |
| VYNE – VYNE Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io